Innovation Pharmaceuticals Inc (IPIX)

[TheProgressive]

January 15th PR.

"The FDA approval now allows for enrollment to begin of the seventh cohort under the amended protocol. The safety committee overseeing the trial has approved dosing to be increased to 165 mg/m2 with a 6-hour maximum infusion timeframe for the seventh cohort."

We can only speculate how far along cohort 7 is, but we do know it is in progress from this PR.